Image source: The Motley Fool. Rigel Pharmaceuticals Inc ( NASDAQ:RIGL ) Nov 5, 2020 , 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Third Quarter 2020. [Operator Instructions] A brief question-and-answer session will follow the formal presentation. [Operator Instructions] It is now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel’s Executive Vice President, Corporate Affairs and General Counsel. Thank you, Ms. Vance. You may begin. Dolly Vance — Executive Vice President, Corporate Affairs and General Counsel Thank you. Welcome to our third quarter 2020 financial results and business update conference call. The financial press release for the third quarter was issued a short while ago and can be viewed along with the accompanying slides for this presentation in the News & Events section of our Investor Relations page on our website, www.rigel.com. As a reminder, during today’s call, we may make forward-looking statements regarding our financial outlook and our plans and timing for regulatory and product development. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of… Read full this story
- Granules India's Q3 profit rises 6%: Highlights from the company's conference call
- Hindustan Zinc reports double digit fall in Q3 earnings: Here are key highlights from conference call
- Can Fin Homes reports healthy growth in Q3 earnings: Here are key highlights from conference call
- Wipro Q3 – A quarter of little complaint, but no spark as well
- RIL Q3 Results: Consumer business drive the show, petchem misses expectations, refining in line
- Bandhan Bank Q3: Net profit spikes 121% YoY, misses Street estimates
- RIL Q3: Highest-ever quarterly net profit; here are 10 key takeaways
- The Case for Michael Avenatti 2020
- Top Q3 earnings, Budget buzz, AGR actions among key factors driving D-Street this week
- Budget 2020: A look at pharma sector's wishlist for FM Nirmala Sitharaman
- Will the Budget and Q3 earnings disappoint the market?
- TCS Q3 revenue below expectations; what should investors do with the stock?
Rigel Pharmaceuticals Inc (RIGL) Q3 2020 Earnings Call Transcript have 332 words, post on www.fool.com at November 6, 2020. This is cached page on CHUTEU. If you want remove this page, please contact us.